Allianz Asset Management GmbH Sells 19,881 Shares of Omega Protein Co. (OME)

Allianz Asset Management GmbH decreased its holdings in shares of Omega Protein Co. (NYSE:OME) by 4.0% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 472,373 shares of the company’s stock after selling 19,881 shares during the quarter. Allianz Asset Management GmbH owned about 2.10% of Omega Protein worth $7,865,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also bought and sold shares of the stock. Alps Advisors Inc. lifted its holdings in shares of Omega Protein by 0.3% during the 2nd quarter. Alps Advisors Inc. now owns 24,619 shares of the company’s stock valued at $441,000 after acquiring an additional 63 shares in the last quarter. Los Angeles Capital Management & Equity Research Inc. lifted its holdings in shares of Omega Protein by 0.3% during the 2nd quarter. Los Angeles Capital Management & Equity Research Inc. now owns 67,722 shares of the company’s stock valued at $1,212,000 after acquiring an additional 190 shares in the last quarter. Schwab Charles Investment Management Inc. lifted its holdings in shares of Omega Protein by 0.6% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 86,703 shares of the company’s stock valued at $1,552,000 after acquiring an additional 532 shares in the last quarter. The Manufacturers Life Insurance Company lifted its holdings in shares of Omega Protein by 3.8% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 17,697 shares of the company’s stock valued at $317,000 after acquiring an additional 652 shares in the last quarter. Finally, Federated Investors Inc. PA lifted its holdings in shares of Omega Protein by 2.1% during the 2nd quarter. Federated Investors Inc. PA now owns 34,289 shares of the company’s stock valued at $614,000 after acquiring an additional 708 shares in the last quarter. Institutional investors and hedge funds own 85.81% of the company’s stock.

Omega Protein Co. (NYSE:OME) opened at $21.95 on Monday. Omega Protein Co. has a 1-year low of $14.50 and a 1-year high of $26.99. The company has a market cap of $493.98, a price-to-earnings ratio of 22.20 and a beta of 0.28.

Omega Protein (NYSE:OME) last issued its quarterly earnings data on Wednesday, November 8th. The company reported $0.09 EPS for the quarter, missing analysts’ consensus estimates of $0.31 by ($0.22). Omega Protein had a return on equity of 6.48% and a net margin of 5.45%. The firm had revenue of $90.30 million during the quarter, compared to analyst estimates of $96.65 million. During the same quarter in the prior year, the firm earned $0.67 EPS. The business’s quarterly revenue was down 17.0% compared to the same quarter last year.

Separately, ValuEngine upgraded shares of Omega Protein from a “hold” rating to a “buy” rating in a report on Friday, December 1st.

WARNING: This piece was posted by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this piece on another website, it was illegally stolen and reposted in violation of United States & international trademark & copyright law. The legal version of this piece can be accessed at https://sportsperspectives.com/2017/12/18/allianz-asset-management-gmbh-sells-19881-shares-of-omega-protein-co-ome.html.

About Omega Protein

Omega Protein Corporation is a nutritional products company that develops, produces and delivers nutritious products. The Company operates through two segments: animal nutrition and human nutrition. The Company’s animal nutrition segment consists of two subsidiaries: Omega Protein, Inc (Omega Protein) and Omega Shipyard, Inc (Omega Shipyard).

Institutional Ownership by Quarter for Omega Protein (NYSE:OME)

Receive News & Ratings for Omega Protein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Protein and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply